Drug Trial Radar · NCT07856420
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
705
Planned (sponsor's estimate)
Start
Sep 29, 2026
Primary completion
Sep 20, 2030
Study completion Sep 28, 2030
Sponsor
- Lead sponsor
- Intra-Cellular Therapies, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess if JNJ-99245354 administered once daily works better to reduce anxiety compared to placebo when given as an additional (adjunctive) therapy in participants with generalized anxiety disorder (GAD; a mental health condition defined by uncontrollable, and excessive worry about everyday events for a long period of time).
Conditions
- Generalized Anxiety Disorder
Interventions
JNJ-99245354Drug
JNJ-99245354 will be administered sublingually.
PlaceboDrug
Placebo will be administered sublingually.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to End of Week 6 in Hamilton Anxiety Rating (HAM-A) Scale Total ScoreTime frame: Baseline, Week 6
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Inland Psychiatric Medical Group Inc
Temecula, California · Recruiting
Nuovida Research Center
Miami, Florida · Recruiting
Voltaire Clinical Research
Springfield, Massachusetts · Recruiting
Fieve Clinical Research Inc
New York, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.